Visualitzant per matèria "Inhibidors enzimàtics"

Visualitzant per matèria "Inhibidors enzimàtics"

Ara es mostren els resultats 1-7 de 7

A novel inhibitor of fatty acid synthase shows activity against HER2+ breast cancer xenografts and is active in anti-HER2 drug-resistant cell lines

2011 Article

Puig i Miquel, Teresa Aguilar, Helena Cufí González, Sílvia Oliveras, Glòria et al.

New synthetic inhibitors of fatty acid synthase with anitcancer activity

2012-05-04 Article

Turrado, Carlos Puig i Miquel, Teresa García-Cárceles, Javier Artola, Marta et al.

Preclinical evaluation of fatty acid synthase and egfrinhibition in triple-negative breast cancer

2016-09-15 Article

Giró Perafita, Ariadna Palomeras Pairet, Sònia Lum, David H. Blancafort Jorquera, Adriana et al.

Epigenetic silencing of TGFBI confers resistance to trastuzumab in human breast cancer

2019-07-05 Article

Palomeras Pairet, Sònia Díaz Lagares, Ángel Viñas, Gemma Setien, Fernando et al.

Fatty Acid Synthase Inhibitor G28 Shows Anticancer Activity in EGFR Tyrosine Kinase Inhibitor Resistant Lung Adenocarcinoma Models

2020-05-19 Article

Polonio Alcalá, Emma Palomeras Pairet, Sònia Torres Oteros, Daniel Relat, Joana et al.

Mimetics of extra virgin olive oil phenols with anti-cancer stem cell activity

2020-11-09 Article

Cuyàs, Elisabet Gumuzio, Juan Lozano Sánchez, Jesús Segura Carretero, Antonio et al.

AZ12756122, a novel fatty acid synthase inhibitor, decreases resistance features in EGFR-TKI resistant EGFR-mutated NSCLC cell models

2022-12-01 Article

Polonio Alcalá, Emma Porta Balanyà, Rut Ruiz Martínez, Santiago Vásquez Dongo, Carmen Amalia et al.

Ara es mostren els resultats 1-7 de 7